Tivic Health Systems Reports on Shareholder Votes

TL;DR

Tivic Health (TIVC) filed an 8-K on Jan 31, 2025, regarding shareholder votes. No major financial news.

AI Summary

Tivic Health Systems, Inc. filed an 8-K on February 5, 2025, reporting on matters submitted to a vote of security holders as of January 31, 2025. The filing details the company's corporate actions and governance, with no specific financial transactions or significant events disclosed in the provided text.

Why It Matters

This filing provides transparency into the corporate governance and decision-making processes of Tivic Health Systems, Inc. regarding matters voted on by its security holders.

Risk Assessment

Risk Level: low — The filing is a routine corporate disclosure regarding shareholder votes and does not indicate any immediate financial risks or significant operational changes.

Key Players & Entities

• Tivic Health Systems, Inc. (company) — Registrant
• January 31, 2025 (date) — Date of earliest event reported
• February 5, 2025 (date) — Filing Date
• Delaware (jurisdiction) — State of Incorporation
• 47685 Lakeview Blvd. (address) — Principal Executive Offices
• Fremont, California (location) — Principal Executive Offices Location
• 94538 (zip_code) — Principal Executive Offices Zip Code

FAQ

Key Financial Figures

• $0.0001 — ch registered Common Stock, par value $0.0001 per share TIVC The Nasdaq Stock Mar

Filing Documents

• tivc-20250131.htm (8-K) — 53KB
• 0000950170-25-014601.txt ( ) — 165KB
• tivc-20250131.xsd (EX-101.SCH) — 24KB
• tivc-20250131_htm.xml (XML) — 5KB

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. On January 31, 2025, Tivic Health Systems, Inc. (the "Company") held a Special Meeting of Stockholders (the "Special Meeting") in a virtual format. At the close of business on December 20, 2024, the record date for the Special Meeting, there were 9,467,327 shares of Company common stock issued and outstanding, which constituted all of the issued and outstanding capital stock of the Company as of the record date. At the Special Meeting, 3,305,437 of the Company's 9,467,327 outstanding shares of common stock entitled to vote as of the record date, or approximately 34.9%, were represented by proxy or in person (virtually), and, therefore, a quorum was present. The proposals voted on at the Special Meeting are more fully described in the Definitive Proxy Statement on Schedule 14A filed by the Company with the Securities and Exchange Commission on January 3, 2025, which information is incorporated herein by reference. The final voting results on the proposals presented for stockholder approval at the Special Meeting were as follows: Proposal No. 1: The Company's stockholders approved the Company's proposal to grant discretionary authority to the Company's board of directors ("Board") to amend the Company's amended and restated certification of incorporation to effect a reverse stock split of all of its issued and outstanding shares of common stock at a ratio of not less than 1-for-2 and not greater than 1-for-30, such ratio to be determined by the Board of at any time within twelve months from the date of the Special Meeting, without further approval or authorization of its stockholders. The final voting results as follows: Votes For Votes Against Abstentions Broker Non-Votes 3,028,943 243,254 33,240 0 Proposal No. 2: The Company's stockholders approved the Company's proposal to authorize the Board, in its discretion, to adjourn the Special Meeting to another place, or a later date o

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TIVIC HEALTH SYSTEMS, INC. Date: February 5, 2025 By: /s/ Jennifer Ernst Name: Jennifer Ernst Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR